Benchling

San Francisco, United States Founded: 2012 • Age: 14 yrs Unicorn
Cloud-based bioinformatics platform is offered for biotech research.

About Benchling

Benchling is a Healthcare company based in San Francisco (United States) founded in 2012 by Ashu Singhal and Sajith Wickramasekara. Cloud-based bioinformatics platform is offered for biotech research. Benchling has raised $411.9 million across 9 funding rounds from investors including Fidelity Investments, Draper and Franklin Templeton. The company has 810 employees. Benchling has completed 1 acquisition, including Overwatch Research. Benchling was last valued at $2.4 billion in September 2024. Its website benchling.com draws about 1.4 million monthly visits. Benchling offers products and services including Benchling Bioresearch, Benchling Bioprocess, and Benchling In Vivo. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its legal entity is BENCHLING, INC. Its competitors include Helix, BioAge Labs and Ingenuity Systems; 3 of its 3 listed competitors have raised funding.

Company details

Provider of a cloud-based bioinformatics platform for biotech research It includes the premier suite for molecular biology research: CRISPR guide design, automated Gibson and Golden Gate cloning, primer design, multiple sequence alignment, and more. Other apps include image analysis like gel annotation and colony counting and protocol design with spreadsheet functionality. The companys tools are cloud-based and so can be shared with people instantly.

  • Headquarters San Francisco, United States
  • Employees 810
  • Founders Ashu Singhal, Sajith Wickramasekara
  • Stage Unicorn
  • Sectors
    Healthcare
  • Website category Science and Education · Biology
  • Website benchling.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Benchling, Inc.
Key Metrics

Products & Services of Benchling

Benchling offers a comprehensive portfolio of products and services, including Benchling Bioresearch, Benchling Bioprocess, and Benchling In Vivo.

Benchling Bioresearch
ELN Software

Platform for planning and recording experiments in biotech research.

Benchling Bioprocess
Workflow Automation

Tools for end-to-end process development in biopharmaceuticals.

Benchling In Vivo
Data Capture

System for managing and analyzing in vivo study data.

Apps and channels of Benchling

its YouTube channel Benchling has 3.25K subscribers and 30 videos.

Benchling
YouTube 3.25K subscribers 30 videos Science & Technology
Open channel

Videos from Benchling

The most watched videos on Benchling's YouTube channel, Benchling (3.25K subscribers). Click a video to play it here.

The Benchling R&D Cloud
12.3K views
Benchling for Academics: Company Overview and Demo
10.6K views
Benchling: Unlocking the power of biotechnology
4.6K views
Benchling: Accelerating life science breakthroughs
4.5K views

More on Benchling.

Funding Insights of Benchling

Benchling has successfully raised a total of $411.9M across 9 strategic funding rounds. The most recent funding activity was a Series F round of $100 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $411.9M
  • Total Rounds 9
  • Last Round Series F β€” $100M
  • First Round $900,000

    (Feb 2014)

  • Investors Count 31

All 9 funding rounds of Benchling with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2021$100MSeries F$6.1BAltimeter Capital, Franklin Templeton Investments
Apr 2021$200MSeries E–Sequoia Capital, Altimeter Capital
May 2020$50MSeries D–Alkeon Capital Management
Jul 2019$34.5MSeries C–Menlo Ventures
Jun 2018$14.5MSeries B–Benchmark
Oct 2016$7MSeries B–Thrive Capital
Apr 2015$5MSeries A–a16z
Aug 2014Seed–Rock Health
–
Feb 2014$900,000Seed–Y Combinator, SV Angel
–
Valuation history
DateValuationStage
Nov 2021$6.1Bβ€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Benchling

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $2.4B (Sep 2024). 31 investors in total: 30 institutional and 1 angel.

Investors in Benchling

Benchling has secured backing from 31 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Fidelity Investments, Draper and Franklin Templeton.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Long/short equity hedge fund and VC fim
altimeter.comBoston, United States
Venture and private equity investments are managed with global diversification.
tigerglobal.comNew York, United States
Long/short and long-only strategies are employed by the hedge fund.
lonepinecapital.comGreenwich, United States
VC fund focused on equity markets
2002alkeoncapital.comNew York, United States
Seed and early-stage technology companies are funded by Lux Capital.
luxcapital.comMenlo Park, United States
Early-stage technology startups are invested in by Thrive Capital.
thrivecap.comNew York, United States
Early-stage venture capital firm investing in AI, healthcare, and tech sectors.
menlovc.com
Spark Capital is engaged in venture capital investments.
sparkcapital.comSan Francisco, United States
Venture capital is provided to technology companies by the firm.
iconiqgrowth.comSan Francisco, United States
Early-stage startups are accelerated via funding and educational programs.
ycombinator.comMountain View, United States
Premium access

Investor details for Benchling

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Benchling

149 people are tracked at Benchling (35 in leadership, 114 in team); the tracked headcount is 810.

NameRoleGroup
Ashu Singhal
Co-Founder & PresidentLeadership
Sajith Wickramasekara
FounderLeadership
Sherine Fazeli
Head Of Total RewardsLeadership
Rachel Black
Head Of Security EngineeringLeadership
Shawna Wolverton
Chief Product OfficerLeadership
Cindy Sun
Head Of Tax And Treasury, Cpa, MSTLeadership
Julie Hwang
Head of LegalLeadership
Meg Makalou
VP, PeopleLeadership
Jannick Bendtsen
Head Of PipebioLeadership
Ada Ling
Head Of Procure To PayLeadership
Stephen Deasy
Head of TechnologyLeadership
Rimas Silkaitis
Head Of Product - PlatformLeadership
Nicholas Floeck
Head Of Product Management (analytics & Automation)Leadership
Derek Halliday
Head Of Product - ApplicationsLeadership
Leah Janoff
Head Of SEC Reporting & Technical AccountingLeadership
James Pycock
Head Of Core Applications, Product ManagementLeadership
Christian Arca
Head Of Systems Of Record ProductLeadership
Michael Weinberg
Head Of Engineering ProductivityLeadership
Ron Gill
Chief Financial OfficerLeadership
Evan Eng
Head Of Finance, Corporate, G&a, R&d & MarketingLeadership

129 more people are available in the full profile.

Premium access

Complete people profiles for Benchling

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Benchling

Benchling has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Overwatch Research.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Clinical data and workflows are managed through an online platform.
overwatchresearch.comBelfast, United Kingdom2017Feb 2022β€’β€’β€’β€’
Premium access

Complete acquisition details for Benchling

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Benchling

5 dated milestones of Benchling across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Benchling is founded.
  2. Funding First funding round of $900K.
  3. Milestone Reaches Unicorn status.
  4. Funding Latest funding round, Series F, of $100.0M.
  5. Acquisition Acquires Overwatch Research.

Competitors of Benchling

Benchling has 3 listed competitors in our database, 3 of them funded. They include Helix, BioAge Labs and Ingenuity Systems.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
helix.com2015San Francisco, United States$435M
Genomic database for clinical research is provided.
bioagelabs.com2015Vallejo, United States$293.9M43
Bioinformatics platform is provided for biomarkers and drug discovery.
ingenuity.com1998Redwood, United States$20.4M30
Genomic data is analyzed and interpreted via web-based applications.
Premium access

Detailed competitors of Benchling

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Benchling

The website of Benchling (benchling.com) receives about 1.4M visits a month and ranks #36,159 among all websites worldwide, #2,130 in Biology.

  • Monthly visits
    1.4M

    ▲ 14.9% vs previous month

  • Unique visitors
    201.3K

    per month

  • Global rank
    #36,159

    among all websites

  • Category rank
    #2,130

    Science and Education · Biology

Similar websites

Websites whose visitors overlap most with Benchling. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
idtdna.com
100%
505.8K#85,096View details
biorxiv.org
99%
3M#19,954View details
abrf.org
abrf.org
98%
#1,459,091–
addgene.org
addgene.org
98%
#84,256–
cell.com
97%
5M#14,619View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Benchling

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Benchling (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Benchling

Premium access

Complete news archive for Benchling

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Benchling

Benchling was founded in 2012 and raised its 1st funding round 2 years after it was founded.

Benchling is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Benchling is a funded company, having raised a total of $411.9M across 9 funding rounds to date. The company's 1st funding round was a Seed of $900K, raised on Feb 2014.

Benchling has 810 employees.

Provider of a cloud-based bioinformatics platform for biotech research It includes the premier suite for molecular biology research: CRISPR guide design, automated Gibson and Golden Gate cloning, primer design, multiple sequence alignment, and more. Other apps include image analysis like gel annotation and colony counting and protocol design with spreadsheet functionality. The companys tools are cloud-based and so can be shared with people instantly.

Benchling's top competitors include Helix, BioAge Labs and Ingenuity Systems.

Benchling offers Benchling Bioresearch, Benchling Bioprocess, and Benchling In Vivo.

Benchling has made 1 acquisition, including Overwatch Research.

Benchling has 31 investors. Key investors include Fidelity Investments, Draper, Franklin Templeton, Spark Capital, and Alkeon Capital Management.

The valuation of Benchling is $2.4B as of Sep 2024.

Benchling operates through Benchling, Inc..

The website of Benchling receives about 1.4 million visits a month and ranks #36,159 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available